INS and diabetes mellitus: Despite this, our findings are timely as states without copayment caps are considering such policies for insulins, and nationwide efforts are under way to cap out-of-pocket insulin costs for all patients with diabetes in the US, with the majority of the public supporting federal regulation to limit out-of-pocket spending for insulin.34,35,36,37,38